Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR53491
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
All files associated with the entry
Citation: Gagne, Donald; Aubin, Yves. "Complete and Rapid NMR Characterization of Therapeutic Monoclonal Antibodies via Differential Labelling of Fab fragments in Escherichia coli" Anal. Chem. ., .-..
Assembly members:
entity_1, polymer, 229 residues, Formula weight is not available
entity_2, polymer, 214 residues, Formula weight is not available
Natural source: Common Name: E. coli Taxonomy ID: 562 Superkingdom: Bacteria Kingdom: not available Genus/species: Escherichia coli
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET11a
Entity Sequences (FASTA):
entity_1: MQVQLQQPGAELVKPGASVK
MSCKASGYTFTSYNMHWVKQ
TPGRGLEWIGAIYPGNGDTS
YNQKFKGKATLTADKSSSTA
YMQLSSLTSEDSAVYYCARS
TYYGGDWYFNVWGAGTTVTV
SAASTKGPSVFPLAPSSKST
SGGTAALGCLVKDYFPEPVT
VSWNSGALTSGVHTFPAVLQ
SSGLYSLSSVVTVPSSSLGT
QTYICNVNHKPSNTKVDKKA
EPKSCDKTH
entity_2: MQIVLSQSPAILSASPGEKV
TMTCRASSSVSYIHWFQQKP
GSSPKPWIYATSNLASGVPV
RFSGSGSGTSYSLTISRVEA
EDAATYYCQQWTSNPPTFGG
GTKLEIKRTVAAPSVFIFPP
SDEQLKSGTASVVCLLNNFY
PREAKVQWKVDNALQSGNSQ
ESVTEQDSKDSTYSLSSTLT
LSKADYEKHKVYACEVTHQG
LSSPVTKSFNRGEC
| Data type | Count |
| 13C chemical shifts | 1364 |
| 15N chemical shifts | 393 |
| 1H chemical shifts | 795 |
| Entity Assembly ID | Entity Name | Entity ID |
|---|---|---|
| 1 | hcFab | 1 |
| 2 | lc | 2 |
Entity 1, hcFab 229 residues - Formula weight is not available
| 1 | MET | GLN | VAL | GLN | LEU | GLN | GLN | PRO | GLY | ALA | ||||
| 2 | GLU | LEU | VAL | LYS | PRO | GLY | ALA | SER | VAL | LYS | ||||
| 3 | MET | SER | CYS | LYS | ALA | SER | GLY | TYR | THR | PHE | ||||
| 4 | THR | SER | TYR | ASN | MET | HIS | TRP | VAL | LYS | GLN | ||||
| 5 | THR | PRO | GLY | ARG | GLY | LEU | GLU | TRP | ILE | GLY | ||||
| 6 | ALA | ILE | TYR | PRO | GLY | ASN | GLY | ASP | THR | SER | ||||
| 7 | TYR | ASN | GLN | LYS | PHE | LYS | GLY | LYS | ALA | THR | ||||
| 8 | LEU | THR | ALA | ASP | LYS | SER | SER | SER | THR | ALA | ||||
| 9 | TYR | MET | GLN | LEU | SER | SER | LEU | THR | SER | GLU | ||||
| 10 | ASP | SER | ALA | VAL | TYR | TYR | CYS | ALA | ARG | SER | ||||
| 11 | THR | TYR | TYR | GLY | GLY | ASP | TRP | TYR | PHE | ASN | ||||
| 12 | VAL | TRP | GLY | ALA | GLY | THR | THR | VAL | THR | VAL | ||||
| 13 | SER | ALA | ALA | SER | THR | LYS | GLY | PRO | SER | VAL | ||||
| 14 | PHE | PRO | LEU | ALA | PRO | SER | SER | LYS | SER | THR | ||||
| 15 | SER | GLY | GLY | THR | ALA | ALA | LEU | GLY | CYS | LEU | ||||
| 16 | VAL | LYS | ASP | TYR | PHE | PRO | GLU | PRO | VAL | THR | ||||
| 17 | VAL | SER | TRP | ASN | SER | GLY | ALA | LEU | THR | SER | ||||
| 18 | GLY | VAL | HIS | THR | PHE | PRO | ALA | VAL | LEU | GLN | ||||
| 19 | SER | SER | GLY | LEU | TYR | SER | LEU | SER | SER | VAL | ||||
| 20 | VAL | THR | VAL | PRO | SER | SER | SER | LEU | GLY | THR | ||||
| 21 | GLN | THR | TYR | ILE | CYS | ASN | VAL | ASN | HIS | LYS | ||||
| 22 | PRO | SER | ASN | THR | LYS | VAL | ASP | LYS | LYS | ALA | ||||
| 23 | GLU | PRO | LYS | SER | CYS | ASP | LYS | THR | HIS |
Entity 2, lc 214 residues - Formula weight is not available
| 1 | MET | GLN | ILE | VAL | LEU | SER | GLN | SER | PRO | ALA | ||||
| 2 | ILE | LEU | SER | ALA | SER | PRO | GLY | GLU | LYS | VAL | ||||
| 3 | THR | MET | THR | CYS | ARG | ALA | SER | SER | SER | VAL | ||||
| 4 | SER | TYR | ILE | HIS | TRP | PHE | GLN | GLN | LYS | PRO | ||||
| 5 | GLY | SER | SER | PRO | LYS | PRO | TRP | ILE | TYR | ALA | ||||
| 6 | THR | SER | ASN | LEU | ALA | SER | GLY | VAL | PRO | VAL | ||||
| 7 | ARG | PHE | SER | GLY | SER | GLY | SER | GLY | THR | SER | ||||
| 8 | TYR | SER | LEU | THR | ILE | SER | ARG | VAL | GLU | ALA | ||||
| 9 | GLU | ASP | ALA | ALA | THR | TYR | TYR | CYS | GLN | GLN | ||||
| 10 | TRP | THR | SER | ASN | PRO | PRO | THR | PHE | GLY | GLY | ||||
| 11 | GLY | THR | LYS | LEU | GLU | ILE | LYS | ARG | THR | VAL | ||||
| 12 | ALA | ALA | PRO | SER | VAL | PHE | ILE | PHE | PRO | PRO | ||||
| 13 | SER | ASP | GLU | GLN | LEU | LYS | SER | GLY | THR | ALA | ||||
| 14 | SER | VAL | VAL | CYS | LEU | LEU | ASN | ASN | PHE | TYR | ||||
| 15 | PRO | ARG | GLU | ALA | LYS | VAL | GLN | TRP | LYS | VAL | ||||
| 16 | ASP | ASN | ALA | LEU | GLN | SER | GLY | ASN | SER | GLN | ||||
| 17 | GLU | SER | VAL | THR | GLU | GLN | ASP | SER | LYS | ASP | ||||
| 18 | SER | THR | TYR | SER | LEU | SER | SER | THR | LEU | THR | ||||
| 19 | LEU | SER | LYS | ALA | ASP | TYR | GLU | LYS | HIS | LYS | ||||
| 20 | VAL | TYR | ALA | CYS | GLU | VAL | THR | HIS | GLN | GLY | ||||
| 21 | LEU | SER | SER | PRO | VAL | THR | LYS | SER | PHE | ASN | ||||
| 22 | ARG | GLY | GLU | CYS |
sample_1: hcFab_rituximab, [U-13C; U-15N; U-2H; 99% 1HD-Ile,Leu; 99% 1HG-Val], 830 uM; DSS 5 mM; sodium acetate, [U-2H], 20 mM; lc-rituximab 830 uM
sample_2: lc-rituximab, [U-13C; U-15N; U-2H; 99% 1HD-Ile,Leu; 99% 1HG-Val], 540 uM; DSS 5 mM; sodium acetate, [U-2H], 20 mM; hcFab_rituximab 540 uM
sample_conditions_1: pH: 5.0; temperature: 313 K
| Name | Sample | Sample state | Sample conditions |
|---|---|---|---|
| 3D HNCO | sample_1 | isotropic | sample_conditions_1 |
| 3D HN(CA)CO | sample_1 | isotropic | sample_conditions_1 |
| 3D HNCA | sample_1 | isotropic | sample_conditions_1 |
| 3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
| 3D HNCACB | sample_1 | isotropic | sample_conditions_1 |
| 3D HN(CO)CACB | sample_1 | isotropic | sample_conditions_1 |
| 2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
| 2D 1H-15N TROSY | sample_1 | isotropic | sample_conditions_1 |
| 2D 1H-13C HSQC | sample_1 | isotropic | sample_conditions_1 |
| 3D CCH-TOCSY | sample_1 | isotropic | sample_conditions_1 |
| 3D CCH-TOCSY | sample_1 | isotropic | sample_conditions_1 |
| 3D HCCH-TOCSY | sample_1 | isotropic | sample_conditions_1 |
| 3D HCCH-TOCSY | sample_1 | isotropic | sample_conditions_1 |
| 3D HNCO | sample_2 | isotropic | sample_conditions_1 |
| 3D HN(CA)CO | sample_2 | isotropic | sample_conditions_1 |
| 3D HNCA | sample_2 | isotropic | sample_conditions_1 |
| 3D HN(CO)CA | sample_2 | isotropic | sample_conditions_1 |
| 3D HNCACB | sample_2 | isotropic | sample_conditions_1 |
| 3D HN(CO)CACB | sample_2 | isotropic | sample_conditions_1 |
| 2D 1H-15N HSQC | sample_2 | isotropic | sample_conditions_1 |
| 2D 1H-15N TROSY | sample_2 | isotropic | sample_conditions_1 |
| 2D 1H-13C HSQC | sample_2 | isotropic | sample_conditions_1 |
| 3D CCH-TOCSY | sample_2 | isotropic | sample_conditions_1 |
| 3D CCH-TOCSY | sample_2 | isotropic | sample_conditions_1 |
| 3D HCCH-TOCSY | sample_2 | isotropic | sample_conditions_1 |
| 3D HCCH-TOCSY | sample_2 | isotropic | sample_conditions_1 |
TOPSPIN - collection
NMRPipe - processing
NMRViewJ - data analysis
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks